News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Seattle startup HDT Bio raises $3M to support development of COVID-19 vaccine
Seattle-based biotech company HDT Bio raised $3 million in seed funding to support work on its COVID-19 vaccine candidate that uses a cutting-edge, replicating RNA
Fred Hutch opens dedicated research center in Seattle to test treatments for COVID-19 patients
Seattle’s Fred Hutchinson Cancer Research Center announced that it is opening a new facility dedicated solely to testing treatments for people who have COVID-19, one
Is Money the Cure-All? Seattle-area biotech companies are striking deals, but questions loom about the market’s access to talent
Despite an economic downturn, investment in Seattle’s biotech industry hasn’t slowed down this year. With Athira Pharma’s September IPO that raised $204 million, life science
Phase Genomics lands $3.9M in grants to improve testing for chromosomal abnormalities
Seattle-based Phase Genomics announced that it received two National Institutes of Health (NIH) grants totaling $3.9 million over three years. The funding will go towards
Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer
Sonoma Biosciences, which splits operations between South San Francisco and Seattle, received $40 million in financing to develop cell therapies for autoimmune diseases. Traditionally used
Seattle biotech Silverback Therapeutics raises $85M, just six months after raising $78.5M
Silverback Therapeutics announced that it received $85 million in Series C funding, following closely on the heels of a $78.5 million funding round in March